Primary-source record
MaterialTrial registry change
pelacarsen · NCT07625306 registry update
status: NOT_YET_RECRUITING → WITHDRAWN; primary_completion: 2028-12-07 → 2029-01-22; completion: 2028-12-07 → 2029-01-22; enrollment: 240 → 0; why_stopped: → Study terminated by sponsor following the outcome of the Lp(a)HORIZON study (NCT04023552), which did not meet its primary endpoint
Key facts
- Filed
- Oct 15, 2026, 03:20 AM
- Event
- Trial registry change
- Direction
- Neutral
- Company
RPRXRoyalty Pharma- Asset
- pelacarsen
- Source
- ClinicalTrials.gov
- Confidence
- Sourced